The Roundtable: Our Thoughts About Model Based Drug Development

Author: Nirpal Virdee

Nirpal Singh Virdee comes with over 18 years of Life Sciences experience. He is a subject matter expert in the Clinical Development, Regulatory Landscape, Transparency and Disclosure space. He is considered an industry thought leader, having globally presented at conferences. He has sat on industry advisory panels. At Synchrogenix , Nirpal is accountable for business development, client management and consulting for technology enabled services.
Find me on: LinkedIn

Recent Posts

How to Navigate “EMA Policy 70: Publication of Clinical Data” and Ensure Compliance

Nirpal Virdee

The issue of transparency and disclosure of clinical trial data has been growing over the past few years. Clinical trials are essential in offering new therapies to patients. However, individuals participating in these trials put themselves at risk, and therefore, the medical community is obligated to derive as much benefit from that risk as possible. […]

Read More
Topics: Regulatory Writing
Learn More
LinkedIn